Petros Gatsios/LinkedIn
Nov 5, 2025, 06:51
Petros Gatsios Explains Why Europe Must Become Self-Sufficient in Maintaining Its Plasma Supply
PPTA Europe shared on LinkedIn:
”Plasma-derived medicinal products (PDMPs) are vital for patients with rare and serious conditions and can’t be made in a lab.
Yet the supply of these medicines is more important than ever.
In a guest article published in Tagesspiegel Background Gesundheit and E-Health, Petros Gatsios, Chairman of the Plasma Protein Therapeutics Association Germany, explains why Europe must become self-sufficient in maintaining its plasma supply and suggests patient-centric policies to better secure future supplies.
Read more about how Germany can lead the way toward a resilient, self-sufficient model in Europe.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 16:47Arun V. J: Why Healthcare Professionals Need More Than Medical Training
-
Jul 8, 2026, 16:38Mona Alfaraj: What Does This HbA₂ Pattern Suggest?
-
Jul 8, 2026, 16:34Alexandros Tsourpas: One of CIMB’s Top-Performing Papers of 2025
-
Jul 8, 2026, 16:27Jan Sloves: Medial Thigh Perforators – The Veins We Keep Missing
-
Jul 8, 2026, 16:23William Aird: A Basic Architecture of Hematology
-
Jul 8, 2026, 16:09Abdulrahman Katib: New Leadership for Better VTE Care
-
Jul 8, 2026, 16:09Does MPN Change the Outlook After Splanchnic Vein Thrombosis? – JTH
-
Jul 8, 2026, 16:01Marianne Yee: The Results of RBC Transfusion Survival Studies
-
Jul 8, 2026, 15:59Shadi Tabibian։ Women and Girls with Hemophilia Should Not Be Invisible in Hemophilia Care